Heights Capital Management’s Bluejay Diagnostics BJDX Stock Holding History
Bought
Maintained
Sold
Other funds holding BJDX
Heights Capital Management's BJDX Position: Q3 2026 in Review
Heights Capital Management sold out of Bluejay Diagnostics (BJDX) in Q3 2026, closing a stake of 8,850 shares — an estimated $42.5K sold.
Heights Capital Management first reported a position in BJDX in Q2 2026 and held it in 1 quarter. The position peaked at $42.5K in Q2 2026. 13 funds tracked by Wall St. Rank hold BJDX as of Q3 2026.
- Heights Capital Management reported no remaining Bluejay Diagnostics position as of Q3 2026 after selling out during the quarter.
- Heights Capital Management sold 8,850 Bluejay Diagnostics shares in Q3 2026, an estimated $42.5K.
- Heights Capital Management first reported a position in Bluejay Diagnostics in Q2 2026 and held it in 1 quarter.
- Heights Capital Management's Bluejay Diagnostics position peaked at $42.5K in Q2 2026.
- 13 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q3 2026.
Based on Heights Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.